HCW Biologics (HCWB) Competitors $5.72 +0.04 (+0.70%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$5.57 -0.15 (-2.64%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HCWB vs. FNCH, CING, AYTU, GDTC, PMN, DARE, MBRX, CMMB, LSB, and XFORShould you be buying HCW Biologics stock or one of its competitors? The main competitors of HCW Biologics include Finch Therapeutics Group (FNCH), Cingulate (CING), Aytu BioPharma (AYTU), CytoMed Therapeutics (GDTC), Promis Neurosciences (PMN), Dare Bioscience (DARE), Moleculin Biotech (MBRX), Chemomab Therapeutics (CMMB), LakeShore Biopharma (LSB), and X4 Pharmaceuticals (XFOR). These companies are all part of the "pharmaceutical products" industry. HCW Biologics vs. Its Competitors Finch Therapeutics Group Cingulate Aytu BioPharma CytoMed Therapeutics Promis Neurosciences Dare Bioscience Moleculin Biotech Chemomab Therapeutics LakeShore Biopharma X4 Pharmaceuticals HCW Biologics (NASDAQ:HCWB) and Finch Therapeutics Group (NASDAQ:FNCH) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, media sentiment, analyst recommendations and institutional ownership. Does the media favor HCWB or FNCH? In the previous week, HCW Biologics had 9 more articles in the media than Finch Therapeutics Group. MarketBeat recorded 10 mentions for HCW Biologics and 1 mentions for Finch Therapeutics Group. HCW Biologics' average media sentiment score of 0.50 beat Finch Therapeutics Group's score of 0.00 indicating that HCW Biologics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HCW Biologics 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Finch Therapeutics Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate HCWB or FNCH? HCW Biologics presently has a consensus target price of $35.00, suggesting a potential upside of 511.89%. Given HCW Biologics' stronger consensus rating and higher possible upside, research analysts clearly believe HCW Biologics is more favorable than Finch Therapeutics Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HCW Biologics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Finch Therapeutics Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable earnings and valuation, HCWB or FNCH? HCW Biologics has higher revenue and earnings than Finch Therapeutics Group. Finch Therapeutics Group is trading at a lower price-to-earnings ratio than HCW Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHCW Biologics$832.84K14.78-$30.02M-$14.04-0.41Finch Therapeutics GroupN/AN/A-$74.75M-$8.82-1.47 Which has more volatility and risk, HCWB or FNCH? HCW Biologics has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500. Comparatively, Finch Therapeutics Group has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Do insiders & institutionals have more ownership in HCWB or FNCH? 3.0% of HCW Biologics shares are held by institutional investors. Comparatively, 21.8% of Finch Therapeutics Group shares are held by institutional investors. 42.7% of HCW Biologics shares are held by company insiders. Comparatively, 44.9% of Finch Therapeutics Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is HCWB or FNCH more profitable? Finch Therapeutics Group has a net margin of 0.00% compared to HCW Biologics' net margin of -1,368.55%. HCW Biologics' return on equity of 0.00% beat Finch Therapeutics Group's return on equity.Company Net Margins Return on Equity Return on Assets HCW Biologics-1,368.55% N/A -40.72% Finch Therapeutics Group N/A -69.14%-26.92% SummaryHCW Biologics beats Finch Therapeutics Group on 9 of the 15 factors compared between the two stocks. Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HCWB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCWB vs. The Competition Export to ExcelMetricHCW BiologicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.22M$3.06B$5.66B$9.84BDividend YieldN/A2.28%3.93%4.04%P/E Ratio-0.4120.9283.2726.61Price / Sales14.78200.54451.26176.46Price / CashN/A44.0537.7059.65Price / Book-286.008.0710.556.59Net Income-$30.02M-$53.98M$3.27B$266.12M7 Day Performance65.80%-0.88%0.47%0.17%1 Month Performance33.02%6.20%5.93%3.03%1 Year Performance-67.44%7.13%48.79%19.98% HCW Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCWBHCW Biologics2.4813 of 5 stars$5.72+0.7%$35.00+511.9%-69.0%$12.22M$832.84K-0.4140FNCHFinch Therapeutics Group0.2928 of 5 stars$12.50-1.6%N/A-5.0%$20.08MN/A-1.42190Gap DownHigh Trading VolumeCINGCingulate2.3588 of 5 stars$3.76-9.6%$26.00+591.5%-37.9%$19.78MN/A-0.4420Analyst RevisionAYTUAytu BioPharma3.7089 of 5 stars$2.20flat$10.00+354.5%-2.1%$19.75M$81.66M-3.06160Positive NewsGDTCCytoMed Therapeutics2.531 of 5 stars$1.75-1.7%$5.00+185.7%+40.0%$19.15M$69.50K0.00N/ANews CoveragePositive NewsPMNPromis Neurosciences3.1925 of 5 stars$0.57-8.4%$4.33+667.0%-58.5%$18.47MN/A-2.695Positive NewsDAREDare Bioscience2.2912 of 5 stars$2.02-4.3%$12.00+494.1%-43.1%$18.24M-$17.70K-0.9430MBRXMoleculin Biotech2.9232 of 5 stars$0.60-1.8%$4.00+571.0%-84.6%$18.05MN/A0.0020News CoverageAnalyst ForecastCMMBChemomab Therapeutics3.2006 of 5 stars$0.93-1.1%$8.50+814.0%-59.9%$17.54MN/A-1.5820News CoverageAnalyst ForecastLSBLakeShore Biopharma1.1372 of 5 stars$0.82flatN/A-81.3%$17.03M$85.67M0.00773News CoverageXFORX4 Pharmaceuticals4.0214 of 5 stars$2.93+17.7%$71.17+2,328.9%-81.9%$16.96M$32.77M-0.2080Analyst ForecastGap DownHigh Trading Volume Related Companies and Tools Related Companies Finch Therapeutics Group Competitors Cingulate Competitors Aytu BioPharma Competitors CytoMed Therapeutics Competitors Promis Neurosciences Competitors Dare Bioscience Competitors Moleculin Biotech Competitors Chemomab Therapeutics Competitors LakeShore Biopharma Competitors X4 Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCWB) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCWB Stock Alerts